Clover Health Investments
CLOV | NASDAQ
$4.95
-$0.01 (-0.20%)
At close: Nov 16, 2026, 4:00 PM ET
$4.91
-$0.04 (-0.81%)
After-hours:
Nov 16, 2026, 7:49 PM ET
Clover Health Investments Company Profile
Company profile explainedCompany Profile
Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare Advantage insurance. The company leverages its proprietary software platform, the Clover Assistant, to provide both Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) health plans for individuals eligible for Medicare. In addition to its insurance operations, Clover Health also engages in non-insurance-related business ventures. The company was established in 2014 and its main office is located in Franklin, Tennessee.
Key Executives
| Name | Position |
|---|---|
| Andrew Toy | Co-Founder, Chief Executive Officer & Director |
| Conrad Wai | Chief Executive Officer of Counterpart Health |
| Jamie L. Reynoso | Chief Executive Officer of Medicare Advantage |
| Clay Thornton | Interim Chief Financial Officer |
| Karen Soares | Chief Legal Officer, General Counsel, Senior VP & Corporate Secretary |
| Rachel Fish | Chief People Officer |
| Joseph Frank Oldakowski | VP of Finance, Controller & Principal Accounting Officer |
| Kumar Dharmarajan | Chief Medical Officer of Clover Assistant |
| Vivek Garipalli | Co-Founder & Executive Chairman |
| Wendy Richey | Chief Compliance Officer |
Clover Health Investments
| Country | United States |
| IPO Date | Jun 12, 2020 |
| Industry | Medical - Healthcare Plans |
| Sector | Healthcare |
| Employees | 724 |
| CEO | Andrew Toy |
Contact Details
1209 Orange Street Wilmington,
Delaware 19801 United States
Stock Details
| Ticker Symbol | CLOV |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001801170 |
| CUSIP Number | 18914F103 |
| ISIN Number | US18914F1030 |
| SIC Code | 6324 |
Recent News
- 7 days ago / marketbeat.comClover Health Investments Sees 2027 Growth as Rival Exits New Jersey
- 7 days ago / seekingalpha.comClover Health Investments, Corp. (CLOV) Presents at 2026 UBS Global Healthcare Conference Transcript
- 11 days ago / seekingalpha.comClover Health's Best Earnings Years May Still Be Ahead
- 12 days ago / seekingalpha.comClover Health Investments, Corp. (CLOV) Q3 2026 Earnings Call Transcript
- 12 days ago / marketbeat.comWhat Clover Health Investments (CLOV) Said on Its Q3 Earnings Call
- 28 days ago / globenewswire.comClover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States
- 1 month ago / 247wallst.comAt 67, He’ll Keep His Clover Medicare Advantage Plan for 2027. The Premium Will Stay $0. The Most He Can Be Billed Will Jump $1,144
- 1 month ago / globenewswire.comClover Health to Report Third Quarter 2026 Financial Results on November 4, 2026
- 2 months ago / globenewswire.comClover Health's 2027 Medicare Advantage Plans Emphasize PPO Choice, Preventive Care and Member Value
- 2 months ago / globenewswire.comUPDATE – Clover Health Welcomes Former U.S. Senator Robert Torricelli and Dr. Brian J. Miller M.D.
Add to Watchlist
Select watchlists to add or remove CLOV